Edition:
United States

SQI Diagnostics Inc (SQD.V)

SQD.V on TSX Venture Exchange

0.17CAD
17 Jan 2017
Change (% chg)

-- (--)
Prev Close
$0.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
50,407
52-wk High
$0.45
52-wk Low
$0.15

Latest Key Developments (Source: Significant Developments)

SQI Diagnostics Q4 loss per share $0.03
Tuesday, 6 Dec 2016 05:03pm EST 

Sqi Diagnostics Inc : Qtrly loss per share $0.03 .Sqi diagnostics reports fourth quarter and fiscal 2016 results.  Full Article

SQI Diagnostics Q3 loss per share C$0.02
Thursday, 18 Aug 2016 08:30am EDT 

SQI Diagnostics Inc : SQI Diagnostics reports third quarter 2016 results . Q3 loss per share C$0.02 . Q3 revenue C$235,000 versus C$180,000 .Sees full-year 2016 revenue C$1.0 million.  Full Article

SQI Diagnostics sees increase in Q4 revenue
Tuesday, 19 Jul 2016 09:00am EDT 

Sqi Diagnostics Inc :In Q4 expects to double revenues over previous quarter with bulk of revenue from platform, kit sales.  Full Article

SQI Diagnostics reports Q2 loss per share C$0.01
Friday, 13 May 2016 08:30am EDT 

SQI Diagnostics Inc : SQI Diagnostics reports second quarter 2016 results .Q2 loss per share C$0.01.  Full Article

SQI Diagnostics Inc announces management changes
Wednesday, 17 Feb 2016 12:05pm EST 

SQI Diagnostics Inc:Board of Directors has approved the promotion of Patricia Lie to Vice President Finance and Administration replacing Lennie Ryer who has left the Company as Chief Financial Officer, effective February 15.  Full Article

SQI Diagnostics Inc announces closing of private placement
Tuesday, 15 Dec 2015 05:00pm EST 

SQI Diagnostics Inc:Completed a non-brokered private placement of 7,480,945 units of company at a price of $0.40 per Unit for gross proceeds of $3 million.Intends to use the net proceeds of the Private Placement to fund the Company's product development and commercialization programs, sales and marketing and for general working capital purposes.  Full Article

SQI Diagnostics Inc announces closing of private placement
Thursday, 16 Jul 2015 03:09pm EDT 

SQI Diagnostics Inc:Says raised gross proceeds of approximately C$2.7 million through the first tranche of a non-brokered private placement of 5,330,000 units priced at $0.50 per Unit.Says each Unit will consist of one common share and one common share purchase warrant.Says each common share purchase warrant will entitle the holder to purchase one common share at a price of $0.65 for a period of three years from the date of issuance, subject to accelerated expiry in certain circumstances.Says after giving effect to the issuance of Units in connection with the first tranche of the Private Placement the Company will have 61,716,058 shares outstanding.Says intends to use the net proceeds of the Private Placement to fund the Company's product development and commercialization programs, sales and marketing and for general working capital purposes.  Full Article

SQI Diagnostics Inc announces private placement
Monday, 22 Jun 2015 09:00am EDT 

SQI Diagnostics Inc:Announces private placement with insider participation.Non-brokered private placement of up to 10.6 million units of the company at a price of $0.50 per unit.  Full Article

SQI Diagnostics appoints Chief Financial Officer
Tuesday, 3 Mar 2015 01:12pm EST 

SQI Diagnostics:Appoints Lennie Ryer CPA, CA, CFE to its Management team.In his capacity as CFO he will assist Company in its transition from a development stage to a commercially successful company.Including strategic financing initiatives to advance Company's capital market strategy and to secure funding to drive future growth and further expansion of SQI proprietary technologies.  Full Article

SQI Diagnostics completes tranche of debenture financing
Friday, 30 Jan 2015 03:01pm EST 

SQI Diagnostics Inc:Says it has closed the first tranche of its previously announced non-brokered private placement of secured debentures for gross proceeds of $1.95 mln.Debentures will bear interest at a rate of 10 pct per annum on the principal amount outstanding and will be repayable 60 months from the date issued.Intends to use the net proceeds to fund the company's product development and commercialization programs, sales and marketing and for general working capital purposes.  Full Article

BRIEF-Sqi Diagnostics sells Sqidlite System to Global Pharmaceutical Customer

* SQI sells Sqidlite System to Global Pharmaceutical customer Source text for Eikon: Further company coverage: